Header Ads

Getting a vaccine where it needs to go

Coronavirus Daily
Bloomberg

Here's the latest news from the global pandemic.

Getting a vaccine where it needs to go

Distributing a Covid-19 vaccine might make developing one look easy.

States are putting the finishing touches on plans they're required to send to the federal government by Friday. These will cover whom to vaccinate first, where they will send those doses, how they will collect the data and a slew of other details crucial to seamlessly pulling off the massive inoculation effort.

But there's a big piece of the puzzle missing: Nobody knows which—if any—of the vaccine candidates will be authorized and when. That makes planning ahead challenging.

"It won't be as easy as a vaccine is approved now send it out," said Molly Howell, North Dakota's immunization program manager.

Each of the leading vaccine candidates varies slightly, meaning states may need to refine their strategies once they know which they will be administering. For instance, some need to be stored at 94 Fahrenheit degrees below zero, while others need only be refrigerated. Some require two shots and others just one.

Local leaders don't yet know how many doses they will receive or whom they should administer them to, making planning where to send them somewhat of a mystery. Initial guidelines put health-care workers first. Even that definition can be questionable.

"You have your hospital health-care workers, your private clinic health-care workers, you have your pharmacists, your urgent care, your local health department health-care workers, long-term care health-care workers," said Bob Swanson, director of the division of immunization at the Michigan Department of Health and Human Services.

Friday marks an important day in the planning phase. It's just one step in a complex process.—Angelica LaVito

Latest podcast

U.S. Vaccine Distribution Strategy Is a Mess

States are racing the clock to meet a Friday deadline from the Federal government to submit plans to distribute a vaccine, once an effective one is ready. But Angelica LaVito reports that they're putting together their strategies effectively blindfolded. Get the latest episode here

 

What you should read

Another Sign of Covid's Toll on Higher Education
U.S. colleges are seeing sharp declines in enrollment this semester.
Russia to Miss Vaccine Goal Amid Setbacks
"To have 30 million doses by year-end is impossible, it is nonsense."
Covid Gives Tourism a Chance to Curb Damage
Some countries don't want mass tourism again, even when Covid ends.
Pfizer, BioNTech Vaccine Trial Remains on Track
The partners could potentially be first to show if a Covid-19 shot works. 
Grim Reality Sets in Across U.S. Hospital Sector
Growing cases threaten hospitals' survival just when they're needed most. 

Know someone else who would like this newsletter? Have them sign up here.

Have any questions, concerns, or news tips on Covid-19 news? Get in touch or help us cover the story.

Like this newsletter? Subscribe for unlimited access to trusted, data-based journalism in 120 countries around the world and gain expert analysis from exclusive daily newsletters, The Bloomberg Open and The Bloomberg Close.

No comments